First Hawaiian Bank’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-40,831
Closed -$700K – 105
2024
Q4
$700K Hold
40,831
– – 0.02% 526
2024
Q3
$816K Sell
40,831
-48,869
-54% -$760K 0.03% 483
2024
Q2
$1M Sell
89,700
-32,315
-26% -$271K 0.03% 369
2024
Q1
$805K Sell
122,015
-34,606
-22% -$189K 0.02% 461
2023
Q4
$708K Sell
156,621
-3,549
-2% -$13.1K 0.02% 487
2023
Q3
$573K Hold
160,170
– – 0.02% 524
2023
Q2
$591K Sell
160,170
-27,603
-15% -$102K 0.02% 536
2023
Q1
$622K Hold
187,773
– – 0.02% 521
2022
Q4
$729K Sell
187,773
-78,356
-29% -$242K 0.03% 447
2022
Q3
$647K Sell
266,129
-14,507
-5% -$34.8K 0.03% 447
2022
Q2
$556K Sell
280,636
-95,145
-25% -$187K 0.02% 505
2022
Q1
$688K Sell
375,781
-137,810
-27% -$215K 0.02% 500
2021
Q4
$724K Buy
+513,591
New +$675K 0.02% 483

Other funds holding ADMA

First Hawaiian Bank's ADMA Position: Q1 2025 in Review

First Hawaiian Bank sold out of ADMA Biologics (ADMA) in Q1 2025, closing a stake of 40,831 shares — an estimated $700K sold.

First Hawaiian Bank first reported a position in ADMA in Q4 2021 and held it in 13 quarters. The position peaked at $1M in Q2 2024. 347 funds tracked by Wall St. Rank hold ADMA as of Q1 2025.

  • First Hawaiian Bank reported no remaining ADMA Biologics position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 40,831 ADMA Biologics shares in Q1 2025, an estimated $700K.
  • First Hawaiian Bank first reported a position in ADMA Biologics in Q4 2021 and held it in 13 quarters.
  • First Hawaiian Bank's ADMA Biologics position peaked at $1M in Q2 2024.
  • 347 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.